SNTL

 
Common Stock Alternative Reporting
Pink Current Information
Verified Company Profile 11/29/2016
Contact Info
  • 123 W. Nye Lane, Suite 129
  • Carson City, NV 89706

Business Description


 
Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Audited Financials Unaudited
Latest Report Sep 30, 2016 Quarterly Report
CIK 0001443475
Fiscal Year End 12/31
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 9999 - Nonclassifiable establishments
Incorporated In: NV, USA
Year of Inc. 2004
Employees Not Available
Company Officers/Contacts
Mark J Osgood President
Mathew McMurdo General Counsel
Company Directors
Mark Dorey
Service Providers
Accounting/Auditing Firm

Not Available
Securities Counsel
Matthew McMurdo, Esq.
28 West 44th Street
16th Floor
New York, NY, 10036
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Syncronys International, Inc. until 4-2013
  • Formerly=LGM Biopharma, Inc. until 12-07
  • Formerly=China Northwest Biotech Corp. until 6-07
  • Formerly=AVL Global, Inc. until 2-06
SNTL Security Details
Share Structure
Market Value1 $3,031,263 a/o Mar 24, 2017
Authorized Shares 850,000,000 a/o Jun 30, 2016
Outstanding Shares 673,613,904 a/o Jun 30, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 230,665,309 a/o Mar 31, 2016
Par Value No Par Value
Transfer Agent(s)
Pacific Stock Transfer Co.
Shareholders
Shareholders of Record 257 a/o Mar 31, 2013
Short Selling Data
Short Interest 0 (-100%)
Feb 29, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security